Comparison of the biological activity of synthetic N-acylated asparagine or serine linked monosaccharide lipid A analogs

Immunobiology

Volumn 196, Issue 4, 1996, Pages 321-331

  Shimizu, Tadayori ^a   Iwamoto, Yoshihisa ^a   Yanagihara, Yasutake ^a   Ryoyama, Kazuo ^a   Suhara, Yoshitomo ^b   Ikeda, Kiyoshi ^b   Achiwa, Kazuo ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE DERIVATIVE; GALACTOSAMINE; GAMMA INTERFERON; LIPID A; MONOSACCHARIDE; MURAMYL DIPEPTIDE; NITRIC OXIDE; SERINE; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN L 929; CYTOLYSIS; DNA SYNTHESIS; FIBROSARCOMA; LETHALITY; MITOGENICITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN CELL; TOXICITY;

EID: 0030498663     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80055-6     Document Type: Article

References (30)

1. RIETSCHEL, E. T., T. KIRIKAE, F. U. SCHAD, U. MAMAT, G. SCHMIDT, H. LOPPNOW, A. J. ULMER, U. ZÄHRINGER, U. SEYDEL, F. D. PADOVA, M. SCHREIER, and H. BRADE. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. Fabsa J. 8: 217.
2. MATSUURA, M., Y. KOJIMA, J. Y. HOMMA, Y. KUBOTA, A. YAMAMOTO, M. KISO, and A. HASEGAWA. 1984. Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A. Febs Lett. 167: 226.
3. KUMAZAWA, Y., M. MATSUURA, J. Y. HOMMA, Y. NAKATSURU, M. KISO, and A. HASEGAWA. 1985. B-cell activation and adjuvant activities of chemically synthesized of the nonreducing sugar moiety of lipid A. Eur. J. Immunol. 15: 199.
4. SHIMIZU T., S. AKIYAMA, T. MASUZAWA, Y. YANAGIHARA, S. NAKAMOTO, T. TAKAHASHI, K. IKEDA, and K. ACHIWA. 1985. Antitumor activity and biological effects of chemically synthesized monosaccharide analogues of lipid A. Chem. Pharm. Bull. 33: 4621.
5. SHIMIZU T., S. AKIYAMA, T. MASUZAWA, Y. YANAGIHARA, S. NAKAMOTO. T. TAKAHASHI, K. IKEDA, and K. ACHIWA. 1986. Comparison of biological activities of chemically synthesized monosaccharide analogues of reducing and nonreducing sugar moieties of lipid A. Chem. Pharm. Bull. 34: 5169.
6. SHIMIZU, T., K. SUGUYAMA, Y. IWAMOTO, Y. YANAGIHARA, T. ASAHARA, K. IKEDA, and K. ACHIWA. 1994. Biological activities of chemically synthesized N-acylated serine linked lipid A analog in mice. Int. J. Immunopharmac. 16: 659.
7. SHIMIZU, T., K. IIDA, Y. IWAMOTO, Y. YANAGIHARA, K. RYOYAMA, T. ASAHARA, K. IKEDA, and K. ACHIWA. 1995. Biological activities and antitumor effects of synthetic lipid A analog linked N-acylated serine. Int. J. Immunopharmac. 17: 425.
8. SUHARA, Y., M. ARAKAWA, K. IKEDA, and K. ACHIWA. 1994. Lipid A and related compounds. ΓIX. Synthesis of biologically active N-acylated L-asparagine-containing D-glucosamine derivatives structurally related to lipid A. Chem. Pharm. Bull. 42: 2526.
9. NAKAMOTO, S., T. TAKAHASHI, K. IKEDA, and K. ACHIWA. 1985. Efficient of novel monosaccharide analogs of lipid A. Chem. Pharm. Bull 33: 4098.
10. IKEDA, K., T. ASAHARA, and K. ACHIWA. 1993. Synthesis of biologically active N-acylated L-serine-containing D-glucosamine-4-phosphate derivatives of lipid A. Chem. Pharm. Bull. 41: 1879.
11. WESTPHAL, O., O. LÜDERITZ, and F. BISTER. 1952. Über die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforsch. 7b: 148.
12. SHIMIZU T., S. AKIYAMA, T. MASUZAWA, Y. YANAGIHARA, S. NAKAMOTO, and K. ACHIWA. 1987. Biological activities of chemically synthesized 2-keto-3-deoxyoctonic acid-(α2→6)-D-glucosamine analogs of lipid A. Infect. Immun. 55: 2287.
13. GALANOS, C., M. A. FREUDENBERG, and W. REUTTER. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. natn. Acad. Sci. USA. 76: 5939.
14. DRYSDALE, B. E., C. M. ZACHARCHUK, and H. S. SHIN. 1983. Mechanism of macrophage-mediated cytotoxicity: production of soluble cytotoxic factor. J. Immunol. 131: 2362.
15. DING, A. H., C. F. NATHAN, and D. J. STUEHR. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407.
16. BULUSU, M. A. R. C., P. WALDSTÄTTEN, J. HILDEBRANDT, E. SCHULTZE, and G. SCHULZ. 1992. Acylic analogues of lipid A: synthesis and biological activities. J. Med. Chem. 35: 3436.
17. PEDRON, T., G. GIRARD, J. EUSTACHE, M. A. R. C. BULUSU, I. MACHER, H. RADZYNER-VYPLEL, P. L. STÜTZ, and R. CHABY. 1992. New synthetic analogs of lipid A as lipopolysac-charide agonists or antagonists of B-lymphocyte activation. Int. Immunol. 4: 533.
18. KAWAI, Y., and K. AKAGAWA. 1989. Macrophage activation by an ornithine-containing lipid or a serine-containing lipid. Infect. Immun. 57: 2086.
19. BEUTLER, B., I. W. MILSARK, and A. C. CERAMI. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science. 229: 869.
20. ZUCKERMAN, S. H., and N. QURESHI. 1992. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on coricosterone induction. Infect. Immun. 60: 2581.
21. MATSUURA, M., M. KISO, A. HASEGAWA, and M. NAKANO. 1994. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-α-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms. Eur. J. Biochem. 221: 335.
22. BENDTZEN, K. 1988. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol. Lett. 19: 183.
23. BLONDIAU, C., P. LAGADEC, P. LEJEUNE, N. ONIER, J.-E. CAVAILLON, and J.-F. JEANNIN. 1994. Correlation between the capacity to active macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species. Immunobiol. 190: 243.
24. WRIGHT, S. D., R. A. RAMOS, P. S. TOBIAS, R. J. ULEVITCH, and J. C. MATHISON. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249: 1431.
25. LEE, J. D., K. KATO, P. S. TOBIAS, T. N. KIRKLAND, and R. J. ULEVITCH. 1992. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 175: 1697.
26. NAKATSUKA, M., KAMAZAWA, M. MATSUURA, J. Y. HOMMA, M. KISO, and A. HASEGAWA. 1989. Enhancements of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A subunits analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives. Int. J. Immunopharmac. 11: 349.
27. SHIMIZU, T., Y. OHTSUKA, T. MASUZAWA, Y. YANAGIHARA, K. NAKAMOTO, T. TAKAHASHI, K. IKEDA, and K. ACHIWA. 1990. Antitumor activity against Meth A fibrosarcoma and biological activities of synthetic monosaccharide analogs of lipid A in mice. Molec. Biother. 2: 110.
28. SHIMIZU, T., Y. OHTSUKA, Y. YANAGIHARA, H. ITOH, S. NAKAMOTO, and K. ACHIWA. 1991. Combined effects of synthetic lipid A analogs and muramyl-dipeptide on antitumor activity against Meth A fibrosarcoma in mice. Int. J. Immunopharmac. 13: 605.
29. SHIMIZU, T., Y. IWAMOTO, Y. YANAGIHARA, K. IKEDA, and K. ACHIWA. 1992 Combined effect of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice. Int. J. Immunopharmac. 14: 1415.
30. AMANO, K., E. RIBI, and L. CANTRELL. 1983. Structural requirements of endotoxic glycolipid for antitumor and toxic activity. J. Biochem. 93: 1391.